"Adenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant epithelial tumor with a glandular organization.
Descriptor ID |
D000230
|
MeSH Number(s) |
C04.557.470.200.025
|
Concept/Terms |
Adenocarcinoma- Adenocarcinoma
- Adenocarcinomas
- Adenoma, Malignant
- Adenomas, Malignant
- Malignant Adenoma
- Malignant Adenomas
Carcinoma, Granular Cell- Carcinoma, Granular Cell
- Carcinomas, Granular Cell
- Granular Cell Carcinoma
- Granular Cell Carcinomas
- Adenocarcinoma, Granular Cell
- Adenocarcinomas, Granular Cell
- Granular Cell Adenocarcinoma
- Granular Cell Adenocarcinomas
Adenocarcinoma, Tubular- Adenocarcinoma, Tubular
- Adenocarcinomas, Tubular
- Tubular Adenocarcinoma
- Tubular Adenocarcinomas
- Carcinoma, Tubular
- Carcinomas, Tubular
- Tubular Carcinoma
- Tubular Carcinomas
Carcinoma, Cribriform- Carcinoma, Cribriform
- Carcinomas, Cribriform
- Cribriform Carcinoma
- Cribriform Carcinomas
Adenocarcinoma, Basal Cell- Adenocarcinoma, Basal Cell
- Adenocarcinomas, Basal Cell
- Basal Cell Adenocarcinoma
- Basal Cell Adenocarcinomas
Adenocarcinoma, Oxyphilic- Adenocarcinoma, Oxyphilic
- Adenocarcinomas, Oxyphilic
- Oxyphilic Adenocarcinoma
- Oxyphilic Adenocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Adenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Adenocarcinoma".
- Adenocarcinoma
- Adenocarcinoma in Situ
- Adenocarcinoma, Bronchiolo-Alveolar
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenocarcinoma, Mucinous
- Adenocarcinoma, Papillary
- Adenocarcinoma, Scirrhous
- Adenocarcinoma, Sebaceous
- Adrenocortical Carcinoma
- Carcinoid Tumor
- Carcinoma, Acinar Cell
- Carcinoma, Adenoid Cystic
- Carcinoma, Ductal
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Islet Cell
- Carcinoma, Lobular
- Carcinoma, Mucoepidermoid
- Carcinoma, Neuroendocrine
- Carcinoma, Renal Cell
- Carcinoma, Signet Ring Cell
- Carcinoma, Skin Appendage
- Cholangiocarcinoma
- Choriocarcinoma
- Cystadenocarcinoma
- Eccrine Porocarcinoma
- Paget Disease, Extramammary
- Pulmonary Adenomatosis, Ovine
This graph shows the total number of publications written about "Adenocarcinoma" by people in this website by year, and whether "Adenocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 35 | 15 | 50 |
1995 | 61 | 18 | 79 |
1996 | 50 | 15 | 65 |
1997 | 43 | 15 | 58 |
1998 | 53 | 16 | 69 |
1999 | 58 | 10 | 68 |
2000 | 48 | 25 | 73 |
2001 | 56 | 10 | 66 |
2002 | 61 | 10 | 71 |
2003 | 81 | 30 | 111 |
2004 | 63 | 33 | 96 |
2005 | 103 | 37 | 140 |
2006 | 103 | 25 | 128 |
2007 | 114 | 26 | 140 |
2008 | 125 | 31 | 156 |
2009 | 115 | 28 | 143 |
2010 | 100 | 32 | 132 |
2011 | 122 | 31 | 153 |
2012 | 134 | 29 | 163 |
2013 | 126 | 31 | 157 |
2014 | 114 | 24 | 138 |
2015 | 123 | 17 | 140 |
2016 | 93 | 20 | 113 |
2017 | 114 | 17 | 131 |
2018 | 95 | 22 | 117 |
2019 | 73 | 9 | 82 |
2020 | 91 | 5 | 96 |
2021 | 64 | 9 | 73 |
2022 | 71 | 2 | 73 |
2023 | 65 | 1 | 66 |
2024 | 14 | 0 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adenocarcinoma" by people in Profiles.
-
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut. 2024 Mar 07; 73(4):639-648.
-
Development and Revision of Meaningful Stage Descriptors for M1a Non-Small Cell Lung Cancer. Chest. 2024 Mar; 165(3):490-491.
-
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 03; 22(2):117-135.
-
An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature. 2024 Mar; 627(8004):656-663.
-
Mutant p53 protects triple-negative breast adenocarcinomas from ferroptosis in vivo. Sci Adv. 2024 Feb 16; 10(7):eadk1835.
-
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open. 2024 Feb 05; 7(2):e240260.
-
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032). J Immunother Cancer. 2024 Feb 05; 12(2).
-
Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Front Immunol. 2024; 15:1324093.
-
Evidence to Date on the Therapeutic Potential of Zolbetuximab in Advanced Gastroesophageal Adenocarcinoma. Curr Oncol. 2024 Feb 01; 31(2):769-777.
-
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study. Thyroid. 2024 Mar; 34(3):347-359.